Anecortave
- Level
- Commodity
- Parent
- 51422400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51422403This classification denotes an angiogenesis inhibitor with the molecular formula C21H28O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R5Y8O51589, chemically known as 17-alpha,21-dihydroxypregna-4,9(11)-diene-3,20-dione 21-acetate but generally known as anecortave, which bears US NIH Compound Identifier 111332. anecortave most often comes in base and acetate forms. World Health Organization schedules anecortave in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule anecortave under HS 29372900 and SITC 54153. As of Q4 2014, ANECORTAVE remains the US FDA Preferred Term for this commodity. SMILES: CC(=O)OCC(=O)C1(CCC2C1(CC=C3C2CCC4=CC(=O)CCC43C)C)O.
Same parent
Under 51422400 · 37Activities that produce or sell this
KBLI · 9Inherited from family 51420000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.